Abstract
Metoclopramide is a substituted benzamide derivative, structurally similar to procainamide and sulpiride. In behavioral, biochemical, and neuroendocrine tests it displays classic neuroleptic dopamine (DA) antagonist properties; in contrast to other DA antagonists, it lacks potency in currently used DA receptor models. In clinical studies using low doses or dubious measures, it was considered not to be efficacious as an antipsychotic. We now find that it indeed has a clinical profile similar to known neuroleptics when used in a dose range predicted from animal models. The findings raise questions regarding the validity and universality of several predictive models, as well as hypotheses purporting to explain molecular mechanisms of action of neuroleptic agents. The drug's inactivity in receptor models suggests that an as yet unidentified DA receptor subpopulation may be important as the mediator of many DA dependent neurobiologic phenomena.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bateman D, Kahn C, Legg N, Reid J (1978) Metoclopramide in Parkinson's disease. Clin Pharmacol Ther 24:459–464
Borenstein P, Bles G (1965) Effects cliniques et electro-encephalographiques du metoclopramide en psychiatrie. Therapie 20:975–995
Byck R (1975) Drugs and the treatment of psychiatric disorders. In: Goodman L, Gilman A (eds) The pharmacological basis of Therapeutics. MacMillan, New York, p 152
Costall B, Naylor R (1976a) Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine. Eur J Pharmacol 35:161–168
Costall B, Naylor R (1976b) A Comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride, and metoclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems. Eur J Pharmacol 40:9–19
Creese I, Burt D, Snyder S (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481–483
Creese I, Steward K, Snyder SH (1979) Species variations in dopamine receptor binding. Eur J Pharmacol 60:55–66
Elliott P, Jenner P, Marsden C (1978) Atropine manipulation of elevated dopamine turnover caused by haloperidol or substituted benzamide drugs. J Pharm Pharmacol 30:788–791
Hackman R, Pentikainen P, Neuvonen P, Vapaatalo H (1973) Inhibition of the apomorphine gnawing compulsion by amantadine. Experentia 34:1524–1525
Healey D, Burger H (1978) Sustained elevation of serum Prolactin by Metoclopramide: A clinical model of idiopathic hyperprolactinemia. J Clin Endocrin Metabol 46:709–714
Horrobin DF, Ally AI, Karmali RA, Karmazyn M, Manku MS, Morgan RO (1978) Prostaglandins and schizophrenia: further discussion of the evidence. Psychol Med 8:43–48
Howard J, Large B, Wedley S, Pullar I (1978) The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro. Life Sci 23:599–604
Hwang P, Guyda H, Friesen H (1971) A radioimmunoassay for human prolactin. Proc Natl Acad Sci (USA) 68:1902–1906
Jenner P, Elliott P, Clow A, Reavill C, Marsden C (1978) A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs. J Pharm Pharmacol 30:46–48
Karatia M, Taub M, Marsden C (1978) Extrapyramidal side-effects of metoclopramide. Lancet II:1254–1255
Kebabian J, Calne D (1979) Multiple receptors for dopamine. Nature 277:93–96
Kebabian J, Petzold G, Greengard P (1972) Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the ‘Dopamine Receptor’. Proc Nat Acad Sci (USA) 69:2145–2149
Lautin A, Wazer H, Stanley M, Rotrosen J, Gershon S (1980) Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata. Life Sci (in press)
Lavy S, Malamed E, Penchas S (1978) Tardive dyskinesia associated with metoclopramide. Brit Med J I:77–78
Melzer H, So R, Miller R, Fang V (1979) Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretion. Life Sci 25:573–584
Mishra R (1978) Effect of substituted benzamide drugs on rat striatal tyrosine hydroxylase. Eur J Pharmacol 51:189–190
Nakra B, Bond A, Lader M (1975) Comparative psychotropic effects of metoclopramide and prochlorperazine in normal subjects. J Clin Pharmacol 15:449–454
Peringer E, Jenner P, Marsden DC (1975) Effect of metoclopramide on turnover of brain dopamine, noradrenaline and 5-hydroxytryptamine. J Pharm Pharmacol 27:442–444
Robinson S, Berney S, Mishra R, Sulser F (1979) The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: Metoclopramide, Thiethylperazine, and molindone as pharmacological tools. Psychopharmacology 64:141–147
roufogalis B, Thornton M, Wade D (1976) Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists. Life Sci 19:927–934
Seeman P, Lee T, Chan-Wang M, Wong K (1976) Antipsychotic drug doses and neuroleptic dopamine receptors. Nature 261:717–718
Spitzer RE, Endicott J, Robins E (1977) Research diagnostic criteria for a selected group of functional disorders, 3rd ed
Stanley M, Wilk S (1979) Striatal DOPAC elevation predicts antipsychotic efficacy of metoclopramide. Life Sci 24:1907–1912
Sulser F, Robinson S (1978) Clinical implications of pharmacological differences among antipsychotic drugs (with particular emphasis on biochemical central synaptic adrenergic mechanisms). In: Lipton M, Di Mascio A, Killam K (eds) Psychopharmacology: A generation of progress. Raven, New York, p 943
Wood G (1978) An adverse reaction to metoclopramide therapy. Brit J Oral Surg 15:278–280
Worms P, Lloyd KG (1979) Predictability and specificity of behavioral screening tests for neuroleptics. In: Zbinden G, Gross S (eds) Pharmacological methods in toxicology — proceddings of an International Workshop. Pergamon, London, p 256
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stanley, M., Lautin, A., Rotrosen, J. et al. Metoclopramide: Antipsychotic efficacy of a drug lacking potency in receptor models. Psychopharmacology 71, 219–225 (1980). https://doi.org/10.1007/BF00433055
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433055